Inomata M, Matsumoto M, Hayashi K, Seto Z, et al. Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors. Anticancer Res 2023;43:3241-3246.
PMID: 37351972